These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 8381504)

  • 1. Inactivated Japanese encephalitis virus vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    MMWR Recomm Rep; 1993 Jan; 42(RR-1):1-15. PubMed ID: 8381504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Japanese encephalitis vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Fischer M; Lindsey N; Staples JE; Hills S;
    MMWR Recomm Rep; 2010 Mar; 59(RR-1):1-27. PubMed ID: 20224546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Japanese encephalitis. Inactivated Japanese encephalitis virus vaccine.
    Wkly Epidemiol Rec; 1994 Apr; 69(16):113-8. PubMed ID: 8003406
    [No Abstract]   [Full Text] [Related]  

  • 4. Japanese Encephalitis Vaccine: Recommendations of the Advisory Committee on Immunization Practices.
    Hills SL; Walter EB; Atmar RL; Fischer M;
    MMWR Recomm Rep; 2019 Jul; 68(2):1-33. PubMed ID: 31518342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of Japanese encephalitis vaccine in children: recommendations of the advisory committee on immunization practices, 2013.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2013 Nov; 62(45):898-900. PubMed ID: 24226626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recommendations for use of a booster dose of inactivated vero cell culture-derived Japanese encephalitis vaccine: advisory committee on immunization practices, 2011.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 May; 60(20):661-3. PubMed ID: 21617632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update on Japanese encephalitis vaccine for children: United States, May 2011.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 May; 60(20):664-5. PubMed ID: 21617633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen.
    Monath TP; Guirakhoo F; Nichols R; Yoksan S; Schrader R; Murphy C; Blum P; Woodward S; McCarthy K; Mathis D; Johnson C; Bedford P
    J Infect Dis; 2003 Oct; 188(8):1213-30. PubMed ID: 14551893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Japanese encephalitis vaccines.
    Wkly Epidemiol Rec; 1998 Oct; 73(44):337-44. PubMed ID: 9817024
    [No Abstract]   [Full Text] [Related]  

  • 10. Further experience with Japanese encephalitis vaccine.
    Sanchez JL; Hoke CH; McCown J; DeFraites RF; Takafuji ET; Diniega BM; Pang LW
    Lancet; 1990 Apr; 335(8695):972-3. PubMed ID: 1970043
    [No Abstract]   [Full Text] [Related]  

  • 11. Long-term follow-up of Japanese encephalitis chimeric virus vaccine: Immune responses in children.
    Chokephaibulkit K; Sirivichayakul C; Thisyakorn U; Pancharoen C; Boaz M; Bouckenooghe A; Feroldi E
    Vaccine; 2016 Nov; 34(46):5664-5669. PubMed ID: 27686833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Product review on the JE vaccine IXIARO.
    Firbas C; Jilma B
    Hum Vaccin Immunother; 2015; 11(2):411-20. PubMed ID: 25621812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Japanese encephalitis: update on vaccines and vaccine recommendations.
    Wilder-Smith A; Halstead SB
    Curr Opin Infect Dis; 2010 Oct; 23(5):426-31. PubMed ID: 20581670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Superior immunogenicity of a freeze-dried, cell culture-derived Japanese encephalitis vaccine (inactivated).
    Kikukawa A; Gomi Y; Akechi M; Onishi T; Manabe S; Namazue J; Fuke I; Ishikawa T; Okuno Y; Ueda S
    Vaccine; 2012 Mar; 30(13):2329-35. PubMed ID: 22306856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection against Japanese encephalitis by inactivated vaccines.
    Hoke CH; Nisalak A; Sangawhipa N; Jatanasen S; Laorakapongse T; Innis BL; Kotchasenee S; Gingrich JB; Latendresse J; Fukai K
    N Engl J Med; 1988 Sep; 319(10):608-14. PubMed ID: 2842677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Japanese encephalitis vaccine and adverse effects among travellers.
    Robinson HC; Russell ML; Csokonay WM
    Can Dis Wkly Rep; 1991 Aug; 17(32):173-4, 177. PubMed ID: 1657420
    [No Abstract]   [Full Text] [Related]  

  • 17. The Vero cell-derived, inactivated, SA14-14-2 strain-based vaccine (Ixiaro) for prevention of Japanese encephalitis.
    Erra EO; Kantele A
    Expert Rev Vaccines; 2015; 14(9):1167-79. PubMed ID: 26162529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy of Japanese encephalitis vaccine in Henan, China: a case-control study.
    Luo D; Yin H; Xili L; Song J; Wang Z
    Southeast Asian J Trop Med Public Health; 1994 Dec; 25(4):643-6. PubMed ID: 7667706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Japanese Encephalitis Vaccine.
    Mileno MD
    R I Med J (2013); 2020 Aug; 103(6):49-50. PubMed ID: 32752568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Japanese encephalitis: current worldwide status.
    Umenai T; Krzysko R; Bektimirov TA; Assaad FA
    Bull World Health Organ; 1985; 63(4):625-31. PubMed ID: 3002650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.